paediatrics Brussels 17

Ramaswamy et al

Luca Massimi No relationship to disclose Massimo Zollo No relationship to disclose Giuseppe Cinalli No relationship to disclose L´aszl´o Bogn´ar No relationship to disclose Almos Klekner No relationship to disclose Tibor Hortob´agyi Stock or Other Ownership: Hortobagyi Med Research Funding: National Brain Research Program, Hungary Sarah Leary No relationship to disclose Ralph P. Ermoian Stock or Other Ownership: Several stocks as part of diversi fi ed fund: Abbott Laboratories, Abbvie, Agilent Technologies, Allergan, Becton, Dickinson and Company, Boston Scienti fi c Corporation, Biogen Idec, Bristol-Myers Squibb, C. R. Bard, Dyax, Gilead Sciences, Haemonetics Corporation, Hospira, Illumina, McKesson Corporation, Mylan, Myrexis, Novartis AG Shareholder, Novo Nordisk AS, P fi zer, Quest Diagnostics, Quintiles Transnational Holdings, Regeneron Pharmaceuticals, F. Hoffmann-La Roche, St Jude Medical, Sano fi Group, UnitedHealth Group, Vertex Pharmaceuticals, Zimmer Holdings, Zoetis James M. Olson Leadership: Blaze Bioscience, Presage Biosciences Stock or Other Ownership: Blaze Bioscience, Presage Biosciences Research Funding: Takeda Patents, Royalties, Other Intellectual Property: Inventor on multiple patents for technologies licensed by Presage Biosciences and Blaze Bioscience. Receive a fraction of the milestone or royalty payments paid to Fred Hutchinson Cancer Research Center by these two companies. Travel, Accommodations, Expenses: Blaze Bioscience, Presage Biosciences Jeffrey R. Leonard No relationship to disclose Corrine Gardner

Roger J. Packer Consulting or Advisory Role: Roche Lyndsey Emery No relationship to disclose William H. Yong Consulting or Advisory Role: Amgen Research Funding: Amgen Horacio Soto No relationship to disclose Linda M. Liau Research Funding: Northwest Biotherapeutics Richard Everson No relationship to disclose Andrew Grossbach Patents, Royalties, Other Intellectual Property: Medtronic Tarek Shalaby No relationship to disclose Michael Grotzer No relationship to disclose Matthias A. Karajannis Consulting or Advisory Role: MedaCorp Research Funding: P fi zer (Inst), Novartis (Inst) David Zagzag No relationship to disclose Helen Wheeler No relationship to disclose Katja von Hoff No relationship to disclose Marta M. Alonso No relationship to disclose Teresa Tuñon No relationship to disclose Ulrich Sch¨uller No relationship to disclose Karel Zitterbart No relationship to disclose Jaroslav Sterba No relationship to disclose Jennifer A. Chan No relationship to disclose Miguel Guzman No relationship to disclose Samer K. Elbabaa Stock or Other Ownership: P fi zer Howard Colman Consulting or Advisory Role: Genentech, Upsher-Smith, Roche,

No relationship to disclose Wieslawa A. Grajkowska No relationship to disclose Lola B. Chambless Stock or Other Ownership: Path fi nder Therapeutics (I) Jason Cain No relationship to disclose Charles G. Eberhart No relationship to disclose Sama Ahsan Travel, Accommodations, Expenses: Merck, Merck (I) Maura Massimino Consulting or Advisory Role: Genentech, Oncoscience Felice Giangaspero No relationship to disclose Francesca R. Buttarelli No relationship to disclose

Novocure, Oxigene, CytRx Corporation, Omniox Research Funding: Newlink Genetics, Plexxikon Girish Dhall No relationship to disclose Paul G. Fisher Stock or Other Ownership: Johnson & Johnson

J OURNAL OF C LINICAL O NCOLOGY

© 2016 by American Society of Clinical Oncology

from 139.18.224.1 Information downloaded from jco.ascopubs.org and provided by at UNIVERSITAETSKLINIKUM LEIPZIG on June 20, 2016 Copyright © 2016 American S ciety of Clinical Oncology. All rights reserved.